NEW YORK (Reuters Health) – For mild persistent asthma, fluticasone propionate with salmeterol cuts the risk of exacerbations more than ciclesonide, but both regimens effectively control daily symptoms.…
NEW YORK (Reuters Health) – An analysis of “real-life” data from a French myocardial infarction (MI) registry fails to show any clinically relevant interaction between clopidogrel and proton…
NEW YORK (Reuters Health) – Among patients with myeloma treated with thalidomide, antithrombotic prophylactic therapies with aspirin, warfarin or enoxaparin reduce thromboembolic events to a similar degree, according…
NEW YORK (Reuters Health) – Results of an early phase trial indicate that wearing an experimental dual-focus soft contact lens can reduce myopia progression in children, according to…
NEW YORK (Reuters Health) – Insulin degludec, an ultra-long-acting basal insulin, provides glycemic control in type 1 diabetes similar to that of insulin glargine but with lower occurrence…
NEW YORK (Reuters Health) – Polyps located in the right hemi-colon, particularly in the cecum, seem to be a substantial and independent risk factor for delayed post-polypectomy hemorrhage,…
NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy added to optimal medical therapy or in addition to an implantable cardioverter defibrillator (ICD) reduces mortality significantly in mild to…
NEW YORK (Reuters Health) – The selective sinoatrial I-f current inhibitor ivabradine lowers heart rate in patients with stable coronary artery disease and impaired left ventricular systolic function…
NEW YORK (Reuters Health) – For treatment of uncomplicated skin abscesses, the efficacy of ultrasound-guided needle aspiration is not on par with incision and drainage – it doesn’t…
